![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 207/36 | (2006.01) |
C07D 207/40 | (2006.01) | ||
C07D 403/12 | (2006.01) | ||
C07D 405/12 | (2006.01) | ||
A61K 31/401 | (2006.01) | ||
A61P 31/20 | (2006.01) |
(11) | Number of the document | 3121164 |
(13) | Kind of document | T |
(96) | European patent application number | 16180180.8 |
Date of filing the European patent application | 2014-05-16 | |
(97) | Date of publication of the European application | 2017-01-25 |
(45) | Date of publication and mention of the grant of the patent | 2020-02-19 |
(46) | Date of publication of the claims translation | 2020-08-10 |
(30) | Number | Date | Country code |
13168291 | 2013-05-17 | EP | |
13175181 | 2013-07-04 | EP | |
13182281 | 2013-08-29 | EP | |
13191209 | 2013-10-31 | EP | |
13198160 | 2013-12-18 | EP | |
14157900 | 2014-03-05 | EP |
(72) |
VANDYCK, Koen, BE
HACHÉ, Geerwin Yvonne Paul, BE
LAST, Stefaan Julien, BE
MC GOWAN, David Craig, BE
ROMBOUTS, Geert, BE
VERSCHUEREN, Wim Gaston, BE
RABOISSON, Pierre Jean-Marie Bernard, BE
|
(73) |
Janssen Sciences Ireland Unlimited Company,
Barnahely Ringaskiddy, Co Cork,
IE
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Sulfamoilpirolamido dariniai ir jų panaudojimas kaip vaistų hepatito B gydymui |
SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B |
Payment date | Validity (years) | Amount | |
2021-04-21 | 8 | 185.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2022-05-16 |